title: Elevated levels of soluble ICAM-1 in serum of patients with acute myeloid leukemia undergoing bone marrow transplantation.
abstract: Serum soluble ICAM-1 concentrations were measured in 10 patients with or without chronic graft-vs.-host disease (GVHD) after allogeneic bone marrow transplantation. The serum soluble ICAM-1 levels in the patients with chronic GVHD were significantly higher than that in the patients without chronic GVHD. The data indicated that serum soluble ICAM-1 is a useful parameter for predicting chronic GVHD.
authors: Third Department of Internal Medicine, Kinki University School of Medicine, Osaka, Japan.
authors: Y
authors: Y
authors: Maeda
authors: J
authors: J
authors: Chihara
authors: F
authors: F
authors: Horiuchi
authors: J
authors: J
authors: Miyatake
authors: Y
authors: Y
authors: Tatsumi
authors: F
authors: F
authors: Urase
authors: K
authors: K
authors: Irimajiri
authors: S
authors: S
authors: Nakajima
authors: A
authors: A
authors: Horiuchi
mesh_terms: D000208:Acute Disease; D016026:Bone Marrow Transplantation; D006086:Graft vs Host Disease / Q000097:blood; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007951:Leukemia, Myeloid / Q000097:blood* / Q000601:surgery*; D012016:Reference Values; D012995:Solubility
chemical_list: D018799:Intercellular Adhesion Molecule-1